Publications

  1. Weber BR, Noble BN, Bearden DT, Crnich CJ, Ellingson KD, McGregor JC, Furuno JP. Antibiotic prescribing upon discharge from the hospital to long-term care facilities: Implications for antimicrobial stewardship requirements in post-acute settings. Infect Control Hosp Epidemiol. Jan 2019;40(1):18-23
  2. Kadoyama KL, Noble BN, Izumi S, Fromme, E. K., Tjia, J., McPherson, ML, Candrain CB, McGregor JC, Ku IY, Furuno JP. Frequency and Documentation of Medication Decisions on Discharge from the Hospital to Hospice Care. J Am Geriatr Soc. Jun 2019;67(6):1258-1262.
  3. Elman MR, Williams CD, Bearden DT, Townes JM, Heintzman JD, Lapidus JA, Kullar R, Markwardt S, Trieu AT, Vahidi AA, McGregor JC. Healthcare-Associated Urinary Tract Infections with Onset Post-hospital Discharge. Infect Control Hosp Epidemiol. May 3 2019;2(5):e193909.
  4. Tallman GB, Vilches-Tran RA, Elman MR, Bearden DT, Taylor JE, Gorman PN, McGregor JC. Empiric Antibiotic Prescribing Decisions Among Medical Residents: The Role of the Antibiogram. Infection Control & Hospital Epidemiology. 2018: 39(5), 578-583.
  5. Koppen L, Suda KJ, Rowan S, McGregor JC, Evans CT. Dentists’ prescribing of antibiotics and opioids to Medicare Part D beneficiaries: Medications of high impact to public health. J Am Dent Assoc. Aug 2018;149(8):721-730.
  6. Furuno JP, Tallman GB, Noble BN, et al. Clinical Outcomes of Oral Suspension versus Delayed-Release Tablet Formulations of Posaconazole for Prophylaxis of Invasive Fungal Infections. Antimicrob Agents Chemother. Oct 2018;62(10).
  7. McGregor JC and Pakyz AL. Enhancing the Utility of Antibiotic Susceptibility Reporting as a Tool for Antimicrobial Stewardship. Curr Treat Options Infect Dis. 2017; 9(1): 80–91.8.
  8. Novak RL, Noble BN, Fromme EK, Tice MO, McGregor JC, Furuno JP. Antibiotic Policies and Utilization in Oregon Hospice Programs. Am J Hosp Palliat Care. 2016; 33(8):777-81.
  9. Williams CD, Chan AT, Elman MR, Kristensen AH, Miser WF, Pignone MP, Stafford RS, McGregor JC. Aspirin use among adults in the U.S.: results of a national survey. Am J Prev Med. 2015; 48(5):501-8.
  10. McGregor JC and Furuno JP. Optimizing research methods used for the evaluation of antimicrobial stewardship programs. Clin Infect Dis. 2014; 59 Suppl 3:S185-92.
  11. Singh H, McGregor JC, Nigro SJ, Higginson A, Larsen GC. Evaluation of collaborative therapy review to improve care of heart failure patients. Am J Manaq Care. 2014 Oct 1;20(10):e425-31.
  12. McGregor JC, Furuno JP. Optimizing research methods used for the evaluation of antimicrobial stewardship programs. Clin Infect Dis. 2014 Oct 15;59 Suppl 3:S185-92.
  13. Furuno JP, Noble BN, Horne KN, McGregor JC, Elman MR, Bearden DT, Walsh EW, Fromme EK.  Frequency of outpatient antibiotic prescription on discharge to hospice care. Antimicrob Agents Chemother. 2014 Sep;58(9):5473-7.
  14. McGregor JC and Harris AD. The need for advancements in the field of risk adjustment for healthcare-associated infections. Infect Control Hosp Epidemiol. 2014 Jan;35(1):8-9.
  15. McGregor JC, Quach Y, Bearden DT, Smith DH, Sharp SE, Guzman-Cottrill JA. Variation in antibiotic susceptibility of uropathogens by age among ambulatory pediatric patients. J Pediatr Nurs. 2014 Mar-Apr;29(2):152-7.
  16. Rosenberg JH, Albrecht JS, Fromme EK, Noble BS, McGregor JC, Comer AC, Furuno JP.  Antimicrobial Use for Symptom Management in Patients Receiving Hospice and Palliative Care: A Systematic Review.  J Palliat Med. 2013 Dec;16(12):1568-74.
  17. Levine PJ, Elman MR, Kullar R, Townes JM, Bearden DT, Vilches-Tran R, McClellan I, McGregor JC.  Validation of Electronic Medical Record Data to Identify Skin and Soft Tissue Infections in Primary Care Settings.  BMC Infect Dis. Apr 10 2013; 13:171.
  18. Stevens V, Concannon C, van Wijngaarden E, McGregor JC.  Validation of the Chronic Disease Score-Infectious Disease (CDS-ID) for the Prediction of Hospital-Associated Clostridium difficile Infection (CDI) within a Retrospective Cohort.  BMC Infect Dis.  Mar 26 2013; 13:150.
  19. McGregor JC, Elman MR, Bearden DT, and Smith DH.  Sex- and Age-specific Trends in Antibiotic Resistance Patterns of Escherichia coli Urinary Isolates from Outpatients.  BMC Family Practice. Feb 22 2013;14(1):25.
  20. McGregor JC, Bearden DT, Townes JM, Sharp SE, Gorman PN, Elman  MR, Mori M, Smith DH.  A Comparison of Antibiograms Developed for Primary Care Outpatients versus Inpatients.  Diag Microbiol Infect Dis.  May 2013; 76(1): 73-79.
  21. Albrecht JS, Gruber-Baldini AL, Fromme EK, McGregor JC, Lee DS, Furuno JP. Quality of hospice care for individuals with dementia.. J Am Ger Soc. Jul;61(7):1060-5.
  22. Ajao AO, Johnson JK, Harris AD, Zhan M, McGregor JC, Thom KA, Furuno JP.  Risk of acquiring extended-spectrum-β-lactamase (ESBL) producing Klebsiella and Escherichia coli from prior room occupants in the intensive care unit.  Infect Control Hosp Epidemiol. May 2013; 34(5): 453-458.
  23. Albrecht JS, McGregor JC, Fromme EK, Bearden DT, Furuno JP.  A nationwide Analysis of Antibiotic Use in Hospice Care in the Final Week of Life.  J Pain Symptom Manage.  In press.
  24. Hartung DM, Svoboda L, Middleton L, McGregor JC.  Generic Substitution of Lamotrigine Among Medicaid Patients with Diverse Indications: A Cohort-Crossover Study.  CNS Drugs. Aug 2012; 26(7):1-10.
  25. McGregor JC, Hartung DM, Allen GP, Taplitz RA, Traver R, Tong T, Bearden DT.  Risk Factors Associated with Linezolid Non-susceptible Enterococcal Infections.  Am J Infect Control.  Nov 2012; 40(9): 886-7.
  26. Schweizer ML, Furuno JP, Harris AD, Johnson JK, Shardell MD, McGregor JC, Thom KA, Cosgrove SE, Sakoulas G, and Perencevich EN.  Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.  BMC Infectious Diseases. Oct 2011; 11:279.
  27. Harris AD, Johnson JK, Thom KA, Morgan DJ, McGregor JC, Ajao AO, Moore AC, Comer AC, Furuno JP. Risk factors for Development of Intestinal Colonization with Imipenem-resistant Pseudomonas aeruginosa in the Intensive Care Unit Setting. Infect Control and Hosp Epidemiol. 2011 Jul;32(7):719-22.
  28. Ajao AO, Harris AD, Roghmann M, Johnson JK, Zhan M, PhD, McGregor JC, Furuno JP.  A Systematic Review of Measurement and Adjustment for Colonization Pressure in Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Enterococci and Clostridium difficile Acquisition Studies. Infect Control and Hosp Epidemiol. May 2011; 32(5): 481-9.
  29. Schweizer ML, Furuno JP, Sakoulas G, Johnson JK, Harris AD, Shardell MD, McGregor JC, Thom KA, Perencevich EN. Increased Mortality with Accessory Gene Regulator (agr)-Dysfunction in Staphylococcus aureus among Bacteremic Patients. Antimicrob Agents Chemother. March 2011; 55(3): 1082-7.
  30. Schweizer ML, Furuno JP, Harris AD, Johnson JK, Shardell MD, McGregor JC, Thom KA, Sakoulas G, Perencevich EN. Empiric Therapy for Staphylococcus aureus Bacteremia May Not Reduce In-Hospital Mortality. PLoS ONE. July 2010; 5(7): e11432.
  31. Weber SG, Miller RR, Perencevich EN, Tolentino J, Meltzer D, Pitrak D, McGregor JC, Sachs GA, Harris AD, Furuno JP.  The prevalence of antimicrobial-resistant bacteria isolated from older versus younger hospitalized adults: results of a two-center study.  J Antimicrob Chemother. Dec 2009; 64(6): 1291-8.
  32. McGregor JC, Dumyati G, Casiano-Colón AE, Chang P, Klevens RM. Usefulness of Antibiogram Surveillance for Methicillin-Resistant Staphylococcus aureus in Outpatient Pediatric Populations. Diagn Microbiol Infect Dis.  May 2009; 64(1):78-83.
  33. Perencevich EN, McGregor JC, Shardell M, Furuno JP, Harris AD, Morris JG, Fisman DN, Johnson JA. Summer Peaks in Gram-Negative Bacterial Infections among Hospitalized Patients. Infect Control Hosp Epidemiol. Dec 2008; 29(12): 1124-1131.
  34. Peer-reviewed Publications (continued)  12.    McGregor JC, Allen GP, Bearden DT. Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis. Ther Clin Risk Manag. Oct 2008; 4(5): 843-853.
  35. Thom KA, Shardell MD, Osih RB, Schweizer ML, Furuno JP, Perencevich EN, McGregor JC, Harris AD.  Controlling for Severity of Illness in Outcome Studies Involving Infectious Diseases: Impact of Measurement at Different Time Points. Infect Control Hosp Epidemiol. Nov 2008; 29(11): 1048-1053.
  36. Schweizer ML, Furuno JP, Harris AD, McGregor JC, Thom KA, Johnson JK, Shardell MD, Perencevich EN. Clinical Utility of Infection Control Documentation of Prior Methicillin-Resistant Staphylococcus aureus Colonization or Infection for Optimization of Empirical Antibiotic Therapy. Infect Control Hosp Epidemiol. Oct 2008; 29:972-974
  37. Thom KA, Schweizer ML, Osih RB, McGregor JC, Furuno JP, Perencevich EN, Harris AD. Impact of Empiric Antimicrobial Therapy on Outcomes in Patients with Escherichia coli and Klebsiella pneumoniae Bacteremia: A Cohort Study. BMC Infect Dis. Sept 2008; 8:116
  38. Harris AD and McGregor JC. The importance of case-mix adjustment for infection rates and the need for more research. Infect Control Hosp Epidemiol. August 2008; 29(8):693-94.
  39. Furuno JP, Schweizer ML, McGregor JC, Perencevich EN. Economics of Infection Control Surveillance Technology: Cost-effective or Just Cost? Am J Infect Control. April 2008; 36: S12-17.
  40. Lodise TP Jr, Patel N, Kwa A, Graves J, Furuno JP, Graffunder E, Lomaestro B, McGregor JC. Predictors of 30-Day Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections: The Impact of Delayed Appropriate Antibiotic Selection. Antimicrob Agents Chemother.  October 2007; 51(10): 3510-3515.
  41. Harris AD, McGregor JC, Johnson JA, Strauss SM, Moor AC, Standiford HC, Hebden JN, Morris, J Glenn Jr. Risk Factors for ICU Admission Colonization with Extended Spectrum ß-Lactamase Producing Bacteria. Emerg Infect Dis. August 2007; 13(8): 1114-1149.
  42. McGregor JC, Rich SA, Harris AD, Perencevich EN, Osih R, Lodise Jr. TP, Miller RR, Furuno JP. A Systematic Review of the Methods Used to Assess the Association Between Appropriate Antibiotic Therapy and Mortality in Bacteremic Patients. Clin Infect Dis. August 1, 2007; 45(3): 329-37.
  43. McGregor JC, Harris AD, Furuno JP, Bradham DD, Perencevich EN.  Relative Influence of Antibiotic Therapy Attributes on Physician Choice in Treating Acute Uncomplicated Pyelonephritis. Med Decis Making. July/August 2007; 27(4): 387-394.
  44. Furuno JP, Harris AD, Wright MO, Hartley DM, McGregor JC, Gaff HD, Hebden JN, Standiford HC, Perencevich EN; Value of Performing Active Surveillance Cultures on Intensive Care Unit Discharge for Detection of Methicillin-Resistant Staphylococcus aureus. Infect Control Hosp Epidemiol June 2007; 28(6): 666-670.
  45. Osih R, McGregor JC, Rich SE, Moore AC, Furuno JP, Perencevich EN, Harris AD. Impact of Empiric Antibiotic Therapy on Outcomes in Patients with Pseudomonas aeruginosa Bacteremia. Antimicrob Agents Chemother. March 2007; 51(3): 839-844.
  46. Lodise TP, Miller CD, Graves J, Furuno JP, McGregor JC, Lomaestro B, Graffunder E, McNutt LA.  Clinical Prediction Tool to Identify Patients with Pseudomonas aeruginosa Respiratory Tract Infections at Greatest Risk for Multi-Drug Resistance.  Antimicrob Agents Chemother. February 2007; 51(2): 417-422.
  47. McGregor JC, Perencevich EN, Furuno JP, Langenberg P, Flannery K, Zhu J, Fink JC, Bradham DD, Harris AD.  Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections.  J Clin Epidemiol. December 2006; 59(12): 1266-1273.
  48. McGregor JC, Weekes E, Forrest GN, Standiford HC, Perencevich EN, Furuno JP, Harris AD.  Impact of a Computerized Clinical Decision Support System on Reducing Inappropriate Antimicrobial Use:  A Randomized Controlled Trial.  J Am Med Inform Assoc. July/August 2006; 13(4): 378-384.
  49. Harris AD, McGregor JC, Furuno JP. What Infection Control Interventions Should Be Undertaken to Control Multidrug-Resistant Gram-Negative Bacteria?  Clin Infect Dis. September 2006; 43(Suppl 2): S57-S61.
  50. Furuno JP, McGregor JC, Harris AD, Johnson JA, Johnson JK, Langenberg P, Venezia RA, Finklestein J, Smith DL, Perencevich, EN.  Identifying High-Risk Groups for Carriage of Antibiotic-Resistant Bacteria.  Arch Intern Med.  March 2006; 166: 580-585.
  51. Harris AD, McGregor JC, Perencevich EN, Furuno JP, Zhu J, Peterson D, Finklestein J. The Use and Interpretation of Quasi-Experimental Studies in Medical Informatics.  J Am Med Inform Assn.  Jan-Feb 2006; 13(1): 16-23.
  52. Furuno JP, Metlay JP, Harnett JP, Wilson J, Langenberg P, McGregor JC, Zhu J, Perencevich EN. Population Antibiotic Susceptibility for Streptococcus pneumoniae and Treatment Outcomes in Common Respiratory Tract Infections.  Pharmacoepidemiol Drug Saf.  Jan 2006; 15(1): 1-9.
  53. Furuno JP, Perencevich EN, Johnson JA, Wright MO, McGregor JC, Morris Jr., JG, Nemoy LL, Roghmann M, Standiford HC, Hebden JN, Strauss SM, Harris AD.  Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococci Co-colonization. Emerg Infect Dis. Oct. 2005; 11(10): 1539-44.
  54. McGregor JC, Kim PW, Perencevich EN, Bradham DD, Furuno JP, Kaye KS, Fink JC, Langenberg P, Roghmann M, Harris AD.  The Utility of the Chronic Disease Score and Charlson Comorbidity Index as Comorbidity Measures for use in Epidemiologic Studies of Antibiotic-Resistant Organisms.  Am J Epidemiol.  March 1, 2005; 161(5): 483-93.
  55. Furuno JP, Harris AD, Wright MO, McGregor JC, Venezia RA, Zhu J, Perencevich EN.  Prediction Rules to Identify Patients with Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci Positive Clinical Culture upon Hospital Admission.  Am J Infect Control.  2004; 32(8): 436-440.